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Author wants to correct the text under the heading of Introduction.

The sentence is written as:

"In the ZENITH study, both treatments had a similar positive effect on regression of cardiac and renal damage, whereas a larger proportion of patients showing carotid plaque regression was observed under zofenopril (31.6% vs. 16.1%;*p* = 0.047), particularly in the subgroup of patients taking the low dose of zofenopril (30 mg) plus HCTZ 12.5 mg (4.7% vs 10.0% irbesartan 150 mg plus HCTZ 12.5 mg;*p* = 0.043)".

The correct sentence should read:

"In the ZENITH study, both treatments had a similar positive effect on regression of cardiac and renal damage, whereas a larger proportion of patients showing carotid plaque regression was observed under zofenopril (31.6% vs. 16.1%;*p* = 0.047). Interestingly, in the subgroup of patients taking the low dose of zofenopril (30 mg) plus HCTZ 12.5 mg the rate of those exhibiting a carotid plaque at study end was significantly lower than that in the subgroup of patients taking the low dose of irbesartan (150 mg) plus HCTZ 12.5 mg (4.7% vs 10.0%;*p* = 0.043)".

The online version of the original article can be found under doi:10.1007/s12325-017-0497-8.
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